JODIE DELESIO: Open Payments
NPI 1407289192 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,709 in 30 payments from 12 companies in 2025. Trend: 2023 $7,473 · 2024 $1,563 · 2025 $14,709
Speaker / faculty: $12,670Food & beverage: $1,040Travel & lodging: $900Consulting: $98
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $11,888 |
| E.R. Squibb & Sons, L.L.C. | 5 | $1,478 |
| Secura Bio, Inc. | 1 | $875 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $109 |
| GENZYME CORPORATION | 1 | $109 |
| Intera Oncology, Inc | 1 | $78 |
| BeiGene USA, Inc. | 1 | $62 |
| Genentech USA, Inc. | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $27 |
| Kite Pharma, Inc. | 1 | $22 |
Products named: RYBREVANT, REBLOZYL, COPIKTRA, Nubeqa, SARCLISA, INTERA, BRUKINSA, Itovebi.
Industry payments across DE — which companies pay providers there.
